Adicet Bio to Present at the Virtual JMP Securities Hematology and Oncology Summit

Rhea-AI Summary

Adicet Bio, Inc. (NASDAQ: ACET) has announced that CEO Chen Schor will present at the virtual JMP Securities Hematology and Oncology Summit on December 6, 2022, at 9:40 a.m. ET. The presentation will focus on the company’s advancements in allogeneic gamma delta T cell therapies for cancer. Investors can access the live audio webcast on Adicet's website, with a replay available for 30 days post-event. Adicet is focused on engineered T cells aimed at enhancing anti-tumor responses, showcasing their innovative approach in oncology.

REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)-- Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced that Chen Schor, President and Chief Executive Officer, will present at the virtual JMP Securities Hematology and Oncology Summit being held from December 6-7, 2022.

Details of the event are as follows:

Date: Tuesday, December 6, 2022
Time: 9:40 a.m. ET

The live audio webcast of the presentation can be accessed on the Investors section of Adicet Bio’s website at http://www.adicetbio.com. An archived replay will be available for 30 days following the presentation.

About Adicet Bio, Inc.

Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors (CARs) and adaptors (CAds), to enhance selective tumor targeting and facilitate innate and adaptive anti-tumor immune response for durable activity in patients. For more information, please visit our website at https://www.adicetbio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221130005976/en/

Adicet Bio., Inc.

Investor and Media Contacts

Anne Bowdidge

abowdidge@adicetbio.com

Janhavi Mohite

Stern Investor Relations, Inc.

212-362-1200

janhavi.mohite@sternir.com

Source: Adicet Bio, Inc.

FAQ

When will Adicet Bio present at the JMP Securities Summit?

Adicet Bio will present on December 6, 2022, at 9:40 a.m. ET.

What is the focus of Adicet Bio's presentation at the summit?

The presentation will focus on their allogeneic gamma delta T cell therapies for cancer.

How can I access the Adicet Bio presentation?

The live audio webcast can be accessed on the Investors section of Adicet Bio’s website.

Is there an archived version of the Adicet Bio presentation?

Yes, an archived replay will be available for 30 days following the presentation.

What is Adicet Bio's stock symbol?

Adicet Bio's stock symbol is ACET.